60
Participants
Start Date
April 24, 2022
Primary Completion Date
October 24, 2022
Study Completion Date
February 28, 2023
Aspirin
100 mg/day orally for 25 days
enoxaparin
40 mg/day subcutaneously for 28 days, with the dose reduced to 20 mg for patients weighing less than 50 kg or with an estimated glomerular filtration rate less than 30 mL/min/1.73 m².
ISSSTEP, Puebla City
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
OTHER_GOV